Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III

Headache

Volumn 56, Issue 3, 2016, Pages 479-490

  Yuan, Hsiangkuo ^a   Silberstein, Stephen D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

neuromodulation; vagus nerve; vagus nerve stimulation

Indexed keywords

CATECHOLAMINE; CYTOKINE; OPIATE;

ANTINOCICEPTION; ASTHMA; DEPRESSION; DRUG RESISTANT EPILEPSY; EPILEPSY; HUMAN; INFLAMMATION; MEDICAL RESEARCH; NEUROMODULATION; NOCICEPTION; PAIN; PRIORITY JOURNAL; REVIEW; SPINAL CORD; VAGUS NERVE; VAGUS NERVE STIMULATION; PHYSIOLOGY;

HUMANS; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84941585484     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12649     Document Type: Review

References (91)

1. Morris GL, Gloss D, Buchhalter J, et al., Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013; 81: 1453-1459.
2. Elliott RE, Morsi A, Kalhorn SP, et al., Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: Long-term outcomes and predictors of response. Epilepsy Behav. 2011; 20: 57-63.
3. Elliott RE, Morsi A, Tanweer O, et al., Efficacy of vagus nerve stimulation over time: Review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS < 10 years. Epilepsy Behav. 2011; 20: 478-483.
4. Stefan H, Kreiselmeyer G, Kerling F, et al., Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: A proof of concept trial. Epilepsia. 2012; 53: e115-e118.
5. Bari AA, Pouratian N., Brain imaging correlates of peripheral nerve stimulation. Surg Neurol Int. 2012; 3: S260-S268.
6. Ryvlin P, Gilliam FG, Nguyen DK, et al., The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: The PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia. 2014; 55: 893-900.
7. Aalbers M, Vles J, Klinkenberg S, Hoogland G, Majoie M, Rijkers K., Animal models for vagus nerve stimulation in epilepsy. Exp Neurol. 2011; 230: 167-175.
8. Cunningham JT, Mifflin SW, Gould GG, Frazer A., Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology. 2008; 33: 1884-1895.
9. Furmaga H, Sadhu M, Frazer A., Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants. J Pharmacol Exp Ther. 2012; 341: 317-325.
10. Magdaleno-Madrigal VM, Martínez-Vargas D, Valdés-Cruz A, Almazán-Alvarado S, Fernández-Mas R., Preemptive effect of nucleus of the solitary tract stimulation on amygdaloid kindling in freely moving cats. Epilepsia. 2010; 51: 438-444.
11. Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A, Fornai F., The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat. 2011; 42: 288-296.
12. Krahl SE, Clark KB., Vagus nerve stimulation for epilepsy: A review of central mechanisms. Surg Neurol Int. 2012; 3: S255-S259.
13. Krahl SE., Vagus nerve stimulation for epilepsy: A review of the peripheral mechanisms. Surg Neurol Int. 2012; 3: S47-S52.
14. Takigawa M, Mogenson GJ., A study of inputs to antidromically identified neurons of the locus coeruleus. Brain Res. 1977; 135: 217-230.
15. Raedt R, Clinckers R, Mollet L, et al., Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J Neurochem. 2011; 117: 461-469.
16. De Taeye L, Vonck K, van Bochove M, et al., The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy. Neurotherapeutics. 2014; 11: 612-622.
17. Krahl SE, Clark KB, Smith DC, Browning RA., Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. 1998; 39: 709-714.
18. Giorgi FS, Blandini F, Cantafora E, et al., Activation of brain metabolism and fos during limbic seizures: The role of locus coeruleus. Neurobiol Dis. 2008; 30: 388-399.
19. Dorr AE, Debonnel G., Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther. 2006; 318: 890-898.
20. Marrosu F, Serra A, Maleci A, Puligheddu M, Biggio G, Piga M., Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res. 2003; 55: 59-70.
21. Woodbury DM, Woodbury JW., Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia. 1990; 31 (Suppl 2): S7-S19.
22. Rutecki P., Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990; 31 (Suppl 2): S1-S6.
23. Krahl SE, Senanayake SS, Handforth A., Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia. 2001; 42: 586-589.
24. Yoo PB, Lubock NB, Hincapie JG, Ruble SB, Hamann JJ, Grill WM., High-resolution measurement of electrically-evoked vagus nerve activity in the anesthetized dog. J Neural Eng. 2013; 10: 026003.
25. Terry Jr RS., Vagus nerve stimulation therapy for epilepsy. In:, Holmes M, ed. Epilepsy Topics. InTech; 2014: 139-160. Available from: http://www.intechopen.com/books/epilepsy-topics/vagus-nerve-stimulation-therapy-for-epilepsy
26. Banzett RB, Guz A, Paydarfar D, Shea SA, Schachter SC, Lansing RW., Cardiorespiratory variables and sensation during stimulation of the left vagus in patients with epilepsy. Epilepsy Res. 1999; 35: 1-11.
27. Tracey KJ., Reflex control of immunity. Nat Rev Immunol. 2009; 9: 418-428.
28. Howland RH., Vagus nerve stimulation. Curr Behav Neurosci Rep. 2014; 1: 64-73.
29. Martelli D, McKinley MJ, McAllen RM., The cholinergic anti-inflammatory pathway: A critical review. Auton Neurosci. 2014; 182: 65-69.
30. Bratton BO, Martelli D, McKinley MJ, Trevaks D, Anderson CR, McAllen RM., Neural regulation of inflammation: No neural connection from the vagus to splenic sympathetic neurons. Exp Physiol. 2012; 97: 1180-1185.
31. Martelli D, Yao ST, McKinley MJ, McAllen RM., Reflex control of inflammation by sympathetic nerves, not the vagus. J Physiol. 2014; 592: 1677-1686.
32. Kenney MJ, Ganta CK., Autonomic nervous system and immune system interactions. Compr Physiol. 2014; 4: 1177-1200.
33. Jänig W., Sympathetic nervous system and inflammation: A conceptual view. Auton Neurosci. 2014; 182: 4-14.
34. Kees MG, Pongratz G, Kees F, Schölmerich J, Straub RH., Via beta-adrenoceptors, stimulation of extrasplenic sympathetic nerve fibers inhibits lipopolysaccharide-induced TNF secretion in perfused rat spleen. J Neuroimmunol. 2003; 145: 77-85.
35. Bockx I, Verdrengh K, Vander Elst I, et al., High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats. Gut. 2011; 61: 604-612.
36. Borovikova LV, Ivanova S, Zhang M, et al., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405: 458-462.
37. He X, Zhao M, Bi X, et al., Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases. Br J Pharmacol. 2014.
38. Yang X, Zhao C, Gao Z, Su X., A novel regulator of lung inflammation and immunity: Pulmonary parasympathetic inflammatory reflex. QJM. 2014; 107: 789-792.
39. Matteoli G, Gomez-Pinilla PJ, Nemethova A, et al., A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut. 2014; 63: 938-948.
40. Pavlov VA, Tracey KJ., The vagus nerve and the inflammatory reflex-Linking immunity and metabolism. Nat Rev Endocrinol. 2012; 8: 743-754.
41. Vida G, Peña G, Deitch EA, Ulloa L., α7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J Immunol. 2011; 186: 4340-4346.
42. Torres-Rosas R, Yehia G, Peña G, et al., Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med. 2014; 20: 291-295.
43. Deutschman CS, Tracey KJ., Sepsis: Current dogma and new perspectives. Immunity. 2014; 40: 463-475.
44. Hays SA, Khodaparast N, Hulsey DR, et al., Vagus nerve stimulation during rehabilitative training improves functional recovery after intracerebral hemorrhage. Stroke. 2014; 45: 3097-3100.
45. Cai PY, Bodhit A, Derequito R, et al., Vagus nerve stimulation in ischemic stroke: Old wine in a new bottle. Front Neurol. 2014; 5: 107.
46. Cheyuo C, Jacob A, Wu R, Zhou M, Coppa GF, Wang P., The parasympathetic nervous system in the quest for stroke therapeutics. J Cereb Blood Flow Metab. 2011; 31: 1187-1195.
47. Levine YA, Koopman F, Faltys M, Zitnik R, Tak PP., Neurostimulation of the cholinergic antiinflammatory pathway in rheumatoid arthritis and inflammatory bowel. Bioelectron Med. 2014; 1: 34-43.
48. Undem BJ, Potenzieri C., Autonomic neural control of intrathoracic airways. Compr Physiol. 2012; 2: 1241-1267.
49. Kistemaker LEM, Gosens R., Acetylcholine beyond bronchoconstriction: Roles in inflammation and remodeling. Trends Pharmacol Sci. 2015; 36: 164-171.
50. Pera T, Penn RB., Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway. Curr Opin Pharmacol. 2014; 16: 72-81.
51. Wasilewski NV, Lougheed MD, Fisher JT., Changing face of β2-adrenergic and muscarinic receptor therapies in asthma. Curr Opin Pharmacol. 2014; 16: 148-156.
52. Bijwadia JS, Hoch RC, Dexter DD., Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder. Chest. 2005; 127: 401-402.
53. Liu R, Song J, Li H, et al., Treatment of canine asthma by high selective vagotomy. J Thorac Cardiovasc Surg. 2014; 148: 683-689.
54. Slebos DJ, Klooster K, Koegelenberg CF, et al., Targeted lung denervation for moderate to severe COPD: A pilot study. Thorax. 2015; 70: 411-419.
55. Hoffmann TJ, Simon BJ, Zhang Y, Emala CW., Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release. Neuromodulation. 2012; 15: 527-536.
56. Miner JR, Lewis LM, Mosnaim GS, Varon J, Theodoro D, Hoffmann TJ., Feasibility of percutaneous vagus nerve stimulation for the treatment of acute asthma exacerbations. Acad Emerg Med. 2012; 19: 421-429.
57. Steyn E, Mohamed Z, Husselman C., Non-invasive vagus nerve stimulation for the treatment of acute asthma exacerbations-results from an initial case series. Int J Emerg Med. 2013; 6: 7.
58. De Couck M, Nijs J, Gidron Y., You may need a nerve to treat pain: The neurobiological rationale for vagal nerve activation in pain management. Clin J Pain. 2014; 30: 1099-1105.
59. Kirchner A, Birklein F, Stefan H, Handwerker HO., Left vagus nerve stimulation suppresses experimentally induced pain. Neurology. 2000; 55: 1167-1171.
60. Kirchner A, Stefan H, Bastian K, Birklein F., Vagus nerve stimulation suppresses pain but has limited effects on neurogenic inflammation in humans. Eur J Pain. 2006; 10: 449-455.
61. Lange G, Janal MN, Maniker A, et al., Safety and efficacy of vagus nerve stimulation in fibromyalgia: A phase I/II proof of concept trial. Pain Med. 2011; 12: 1406-1413.
62. Borckardt JJ, Anderson B, Andrew Kozel F, et al., Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase. 2006; 12: 216-220.
63. Busch V, Zeman F, Heckel A, Menne F, Ellrich J, Eichhammer P., The effect of transcutaneous vagus nerve stimulation on pain perception-An experimental study. Brain Stimulat. 2013; 6: 202-209.
64. Laqua R, Leutzow B, Wendt M, Usichenko T., Transcutaneous vagal nerve stimulation may elicit anti- and pro-nociceptive effects under experimentally-induced pain-A crossover placebo-controlled investigation. Auton Neurosci. 2014; 185: 120-122.
65. Sedan O, Sprecher E, Yarnitsky D., Vagal stomach afferents inhibit somatic pain perception. Pain. 2005; 113: 354-359.
66. Botha C, Farmer AD, Nilsson M, et al., Preliminary report: Modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity. Gut. 2015; 64: 611-617.
67. Suren M, Kaya Z, Ozkan F, Erkorkmaz U, Arbox drawings light down and leftcbox drawings light down and left S, Karaman S., Comparison of the use of the Valsalva maneuver and the eutectic mixture of local anesthetics (EMLA®) to relieve venipuncture pain: A randomized controlled trial. J Anesth. 2013; 27: 407-411.
68. Randich A, Gebhart GF., Vagal afferent modulation of nociception. Brain Res Brain Res Rev. 1992; 17: 77-99.
69. Nahman-Averbuch H, Granovsky Y, Sprecher E, et al., Associations between autonomic dysfunction and pain in chemotherapy-induced polyneuropathy. Eur J Pain. 2014; 18: 47-55.
70. Khasar SG, Green PG, Miao FJ-P, Levine JD., Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. Eur J Neurosci. 2003; 17: 909-915.
71. Randich A, Thurston CL, Ludwig PS, Timmerman MR, Gebhart GF., Antinociception and cardiovascular responses produced by intravenous morphine: The role of vagal afferents. Brain Res. 1991; 543: 256-270.
72. Weissman-Fogel I, Dashkovsky A, Rogowski Z, Yarnitsky D., Vagal damage enhances polyneuropathy pain: Additive effect of two algogenic mechanisms. Pain. 2008; 138: 153-162.
73. Zhang Y, Popovic ZB, Bibevski S, et al., Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009; 2: 692-699.
74. Kong S-S, Liu J-J, Hwang T-C, Yu X-J, Lu Y, Zang W-J., Tumour necrosis factor-α and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Clin Exp Pharmacol Physiol. 2011; 38: 300-306.
75. Tsutsumi T, Ide T, Yamato M, et al., Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc Res. 2008; 77: 713-721.
76. Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J., Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimulat. 2014; 7: 871-877.
77. Schestatsky P, Simis M, Freeman R, Pascual-Leone A, Fregni F., Non-invasive brain stimulation and the autonomic nervous system. Clin Neurophysiol. 2013; 124: 1716-1728.
78. Thayer JF, Sternberg EM., Neural aspects of immunomodulation: Focus on the vagus nerve. Brain Behav Immun. 2010; 24: 1223-1228.
79. Chapleau MW, Sabharwal R., Methods of assessing vagus nerve activity and reflexes. Heart Fail Rev. 2010; 16: 109-127.
80. Kamath MV, Upton AR, Talalla A, Fallen EL., Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man. Pacing Clin Electrophysiol. 1992; 15: 235-243.
81. Kamath MV, Upton AR, Talalla A, Fallen EL., Neurocardiac responses to vagoafferent electrostimulation in humans. Pacing Clin Electrophysiol. 1992; 15: 1581-1587.
82. Taha R, Blaise GA., Update on the pathogenesis of complex regional pain syndrome: Role of oxidative stress. Can J Anaesth. 2012; 59: 875-881.
83. Chae J-H, Nahas Z, Lomarev M, et al., A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res. 2003; 37: 443-455.
84. Nishikawa Y, Koyama N, Yoshida Y, Yokota T., Activation of ascending antinociceptive system by vagal afferent input as revealed in the nucleus ventralis posteromedialis. Brain Res. 1999; 833: 108-111.
85. Evans AR, Jones SL, Blair RW., Effects of vagal afferent nerve stimulation on noxious heat-evoked Fos-like immunoreactivity in the rat lumbar spinal cord. J Comp Neurol. 1994; 346: 490-498.
86. Lyubashina OA, Sokolov AY, Panteleev SS., Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats. Neuroscience. 2012; 222: 29-37.
87. Chandler MJ, Zhang J, Qin C, Foreman RD., Spinal inhibitory effects of cardiopulmonary afferent inputs in monkeys: Neuronal processing in high cervical segments. J Neurophysiol. 2002; 87: 1290-1302.
88. Bohotin C, Scholsem M, Bohotin V, Franzen R, Schoenen J., Vagus nerve stimulation attenuates heat- and formalin-induced pain in rats. Neurosci Lett. 2003; 351: 79-82.
89. Chen SL, Wu XY, Cao ZJ, et al., Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G1441-1449.
90. Clark KB, Krahl SE, Smith DC, Jensen RA., Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol Learn Mem. 1995; 63: 213-216.
91. Peña DF, Childs JE, Willett S, Vital A, McIntyre CK, Kroener S., Vagus nerve stimulation enhances extinction of conditioned fear and modulates plasticity in the pathway from the ventromedial prefrontal cortex to the amygdala. Front Behav Neurosci. 2014; 8: 327.